Correspondence on "development and validation of a nomogram to predict the efficacy of PD-1/PD-L1 inhibitors in patients with nasopharyngeal carcinoma"

被引：0
|
作者：
Ragavendran, Chinnasamy [1 ]
机构：
[1] Saveetha Inst Med & Tech Sci SIMATS, Saveetha Dent Coll & Hosp, Dept Cariol, Chennai 600077, India
来源：
CLINICAL & TRANSLATIONAL ONCOLOGY | 2024年
关键词：
D O I：
10.1007/s12094-024-03808-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1853 / 1854
页数：2
相关论文
共 50 条
  • [31] Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinoma
    Zhang, Jianwei
    Fang, Wenfeng
    Qin, Tao
    Yang, Yunpeng
    Hong, Shaodong
    Liang, Wenhua
    Ma, Yuxiang
    Zhao, Hongyun
    Huang, Yan
    Xue, Cong
    Huang, Peiyu
    Hu, Zhihuang
    Zhao, Yuanyuan
    Zhang, Li
    MEDICAL ONCOLOGY, 2015, 32 (03) : 1 - 6
  • [32] The Prognostic Significance of APOBEC3B and PD-L1/PD-1 in Nasopharyngeal Carcinoma
    Feng, ChangYin
    Zhang, YingYing
    Huang, JianPing
    Zheng, QiaoLing
    Yang, YingHong
    Xu, BenHua
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2021, 29 (03) : 239 - 244
  • [33] Efficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysis
    Elias, Rawad
    Giobbie-Hurder, Anita
    McCleary, Nadine Jackson
    Ott, Patrick
    Hodi, F. Stephen
    Rahma, Osama
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [34] PD-1 and PD-L1 expression in 132 recurrent nasopharyngeal carcinoma: the correlation with anemia and outcomes
    Zhou, Yajuan
    Miao, Jingjing
    Wu, Haijun
    Tang, Hao
    Kuang, Jing
    Zhou, Xiaoyi
    Peng, Yi
    Hu, Desheng
    Shi, Dingbo
    Deng, Wuguo
    Cao, Xinyue
    Zhao, Chong
    Xie, Conghua
    ONCOTARGET, 2017, 8 (31) : 51210 - 51223
  • [35] Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinoma
    Jianwei Zhang
    Wenfeng Fang
    Tao Qin
    Yunpeng Yang
    Shaodong Hong
    Wenhua Liang
    Yuxiang Ma
    Hongyun Zhao
    Yan Huang
    Cong Xue
    Peiyu Huang
    Zhihuang Hu
    Yuanyuan Zhao
    Li Zhang
    Medical Oncology, 2015, 32
  • [36] Clinical observation of the efficacy of PD-1/PD-L1 inhibitors in the treatment of patients with advanced solid tumors
    Wang, Miao
    Zhen, Hongchao
    Jiang, Xiaoyue
    Lu, Yuting
    Wei, Yuhan
    Jin, Jiangtao
    Li, Qin
    IMMUNITY INFLAMMATION AND DISEASE, 2021, 9 (04) : 1584 - 1595
  • [37] Advances in pharmacokinetics and pharmacodynamics of PD-1/PD-L1 inhibitors
    Yan, Ting
    Yu, Lun
    Shangguan, Dangang
    Li, Wei
    Liu, Ni
    Chen, Yun
    Fu, Yilan
    Tang, Jingyi
    Liao, Dehua
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 115
  • [38] Ocular adverse events in PD-1 and PD-L1 inhibitors
    Young, LeAnne
    Finnigan, Shanda
    Streicher, Howard
    Chen, Helen X.
    Murray, James
    Sen, H. Nida
    Sharon, Elad
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (07)
  • [39] Efficacy of PD-1/PD-L1 inhibitors in advanced hepatocellular carcinoma: A systematic review and meta-analysis
    Peng, Tzu-Rong
    Yang, Li-Jou
    Wu, Ta-Wei
    TZU CHI MEDICAL JOURNAL, 2024, 36 (03): : 340 - 348
  • [40] Efficacy and safety of PD-1/PD-L1 inhibitors in patients with Merkel Cell Carcinoma: a systematic review and Meta-analysis
    de Moraes, Francisco Cezar Aquino
    Kreuz, Michele
    de Lara, Isabella Christina Amaral
    Lobo, Artur de Oliveira Macena
    Burbano, Rommel Mario Rodriguez
    BMC CANCER, 2024, 24 (01)
12345